The First Case of Biological Therapy Discontinuation After a Complete Remission Induced by Maintenance Therapy With Adalimumab for Refractory Ulcerative Colitis

Journal of Clinical Medicine Research
doi 10.14740/jocmr1991w
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elmer Press, Inc.

Related search

Tacrolimus Therapy as an Alternative to Thiopurines for Maintaining Remission in Patients With Refractory Ulcerative Colitis

Journal of Clinical Gastroenterology
Gastroenterology
2011English

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

New England Journal of Medicine
Medicine
2005English

Red Cell Abnormalities Associated With Sulphasalazine Maintenance Therapy for Ulcerative Colitis.

Gut
Gastroenterology
1975English

Combination Therapy With Adalimumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis Induced Clinical Remission in a Crohn's Disease Patient With the Loss of Response to Scheduled Adalimumab Maintenance Therapy: A Case Report

Internal Medicine
Internal MedicineMedicine
2012English

Cost-Utility Analysis of Infliximab and Adalimumab for Refractory Ulcerative Colitis

Cost Effectiveness and Resource Allocation
Health Policy
2009English

Complete Remission of Refractory Hodgkin’s Lymphoma in a Patient With AIDS After Single Dose Checkpoint Inhibitor Therapy

Journal of Case Reports and Images in Oncology
2020English

Adalimumab Discontinuation in Patients With Rheumatoid Arthritis After Achieving Sustained Remission

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2018English

DAC-Tam Therapy Induced Complete Remission in a Case With Stage IV Plantar Melanoma.

Skin Cancer
2002English

Early Onset First-Episode Psychosis During Treatment With Thalidomide for Refractory Ulcerative Colitis: A Case Report

Journal of Medical Case Reports
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy